Hvsen Biotechnology Co., Ltd. (300871.SZ)
CNY 11.77
(-0.17%)
CNY 11.77
(-0.17%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 16.78 Million CNY | -68.16% |
| 2022 | 52.7 Million CNY | -60.33% |
| 2021 | 132.86 Million CNY | -11.52% |
| 2020 | 150.15 Million CNY | 118.36% |
| 2019 | 68.76 Million CNY | -3.69% |
| 2018 | 71.4 Million CNY | -19.25% |
| 2017 | 88.42 Million CNY | 78.91% |
| 2016 | 49.42 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -16.4 Million CNY | -961.88% |
| 2024 Q3 | 4.22 Million CNY | 111.9% |
| 2024 Q2 | -35.47 Million CNY | -116.23% |
| 2023 Q1 | 14.85 Million CNY | -43.52% |
| 2023 FY | 16.78 Million CNY | -68.16% |
| 2023 Q4 | 1.9 Million CNY | 286.51% |
| 2023 Q3 | -1.02 Million CNY | -197.92% |
| 2023 Q2 | 1.04 Million CNY | -92.98% |
| 2022 Q2 | 4.48 Million CNY | 121.79% |
| 2022 FY | 52.7 Million CNY | -60.33% |
| 2022 Q1 | 2.02 Million CNY | -84.59% |
| 2022 Q3 | 19.89 Million CNY | 343.18% |
| 2022 Q4 | 26.3 Million CNY | 32.21% |
| 2021 Q4 | 13.13 Million CNY | -28.61% |
| 2021 FY | 132.86 Million CNY | -11.52% |
| 2021 Q3 | 18.4 Million CNY | -51.41% |
| 2021 Q1 | 63.45 Million CNY | 19.25% |
| 2021 Q2 | 37.87 Million CNY | -40.32% |
| 2020 FY | 150.15 Million CNY | 118.36% |
| 2020 Q4 | 53.21 Million CNY | 19.91% |
| 2020 Q3 | 44.37 Million CNY | 62.91% |
| 2020 Q2 | 27.24 Million CNY | 7.57% |
| 2020 Q1 | 25.32 Million CNY | -23.61% |
| 2019 Q3 | 9.31 Million CNY | 0.0% |
| 2019 Q4 | 33.14 Million CNY | 255.69% |
| 2019 FY | 68.76 Million CNY | -3.69% |
| 2018 FY | 71.4 Million CNY | -19.25% |
| 2017 FY | 88.42 Million CNY | 78.91% |
| 2016 FY | 49.42 Million CNY | 0.0% |